These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23165507)

  • 1. Falls in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Facchinetti LD; Araújo AQ; Chequer GL; de Azevedo MF; de Oliveira RV; Lima MA
    Spinal Cord; 2013 Mar; 51(3):222-5. PubMed ID: 23165507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
    Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
    J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of tropical spastic paraparesis/human T-cell lymphotropic virus type 1-associated myelopathy (TSP/HAM)-like among HIV-1-infected patients.
    Casseb J; de Oliveira AC; Vergara MP; Montanheiro P; Bonasser F; Meilman Ferreira C; Smid J; Duarte AJ
    J Med Virol; 2008 Mar; 80(3):392-8. PubMed ID: 18205234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the HTLV-1 proviral load in the peripheral blood of asymptomatic carriers and patients with HTLV-associated myelopathy/tropical spastic paraparesis from a Brazilian cohort: ROC curve analysis to establish the threshold for risk disease.
    Furtado Mdos S; Andrade RG; Romanelli LC; Ribeiro MA; Ribas JG; Torres EB; Barbosa-Stancioli EF; Proietti AB; Martins ML
    J Med Virol; 2012 Apr; 84(4):664-71. PubMed ID: 22337307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Chronic Pain and Its Impact on Quality of Life of Patients With HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Netto EC; Brites C
    Clin J Pain; 2011 Feb; 27(2):131-5. PubMed ID: 20842011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of peripheral neuropathy in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saeidi M; Sasannejad P; Foroughipour M; Shahami S; Shoeibi A
    Acta Neurol Belg; 2011 Mar; 111(1):41-4. PubMed ID: 21510232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.
    Okajima R; Casseb J; Sanches JA
    Int J Dermatol; 2013 Jan; 52(1):63-8. PubMed ID: 23278610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
    Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
    J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clustering of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) and infective dermatitis associated with HTLV-1 (IDH) in Salvador, Bahia, Brazil.
    da Silva JL; Primo JR; de Oliveira Mde F; Batista Eda S; Moreno-Carvalho O; Farré L; Bittencourt AL
    J Clin Virol; 2013 Oct; 58(2):482-5. PubMed ID: 23932323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vestibular-evoked myogenic potential (VEMP) to evaluate cervical myelopathy in human T-cell lymphotropic virus type I infection.
    Felipe L; Gonçalves DU; Santos MA; Proietti FA; Ribas JG; Carneiro-Proietti AB; Lambertucci JR
    Spine (Phila Pa 1976); 2008 May; 33(11):1180-4. PubMed ID: 18469690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Bartholomew C; Jack N; Edwards J; Charles W; Corbin D; Cleghorn FR; Blattner WA
    J Hum Virol; 1998; 1(4):302-5. PubMed ID: 10195256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I.
    Puccioni-Sohler M; Yamano Y; Rios M; Carvalho SM; Vasconcelos CC; Papais-Alvarenga R; Jacobson S
    Neurology; 2007 Jan; 68(3):206-13. PubMed ID: 17224575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Starling AL; Martins-Filho OA; Lambertucci JR; Labanca L; de Souza Pereira SR; Teixeira-Carvalho A; Martins ML; Ribas JG; Carneiro-Proietti AB; Gonçalves DU
    Acta Trop; 2013 Jan; 125(1):75-81. PubMed ID: 23022356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of HTLV-1 proviral load in patients from Salvador, Brazil.
    Olavarria VN; Gomes Ado N; Kruschewsky Rde A; Galvão-Castro B; Grassi MF
    Braz J Infect Dis; 2012; 16(4):357-60. PubMed ID: 22846124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in northeast Iran.
    Shoeibi A; Rafatpanah H; Azarpazhooh A; Mokhber N; Hedayati-Moghaddam MR; Amiri A; Hashemi P; Foroghipour M; Hoseini RF; Bazarbachi A; Azarpazhooh MR
    Acta Neurol Belg; 2013 Dec; 113(4):427-33. PubMed ID: 23568138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
    Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.